Sangamo Therapeutics
SGMO
SGMO
124 hedge funds and large institutions have $196M invested in Sangamo Therapeutics in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
124
Holding in Top 10
–
Calls
$5.37M
Puts
$1.49M
Top Buyers
| 1 | +$3.85M | |
| 2 | +$2.49M | |
| 3 | +$2.4M | |
| 4 |
Renaissance Technologies
New York
|
+$2.22M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.37M |
Top Sellers
| 1 | -$14M | |
| 2 | -$6.14M | |
| 3 | -$2.4M | |
| 4 |
SCM
Suffolk Capital Management
New York
|
-$1.43M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.23M |